June 22, 2021 07:28 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Highly unfair': India on Tokyo Olympics' protocols for Covid-hit nations | No video call: UP Police reject Twitter India head's offer to appear virtually | 21 cases of Delta COVID variant detected in Maharashtra so far: State health minister | Don't believe third front can successfully challenge BJP: Prashant Kishor ahead of Sharad Pawar's meet | Centre proposes changes to e-commerce rules, bans flash sales
Covid-19: clinical trials using Covaxin on children begins Covid19 Vaccine
Image: Unsplash

Covid-19: clinical trials using Covaxin on children begins

India Blooms News Service | @indiablooms | 10 Jun 2021, 09:08 pm

Bengaluru/UNI: In all 30 children, aged 12-18, were administered Covaxin at Mysuru Medical College and Research Institute (MMCRI) as part of Hyderabad-based pharmaceutical major Bharat Biotech's clinical trials.

 

MMCRI is the only site selected in Karnataka for the company's paediatric trials, currently being conducted pan-India across multiple locations.

When the vaccinated kids were followed up telephonically, mild pain at the injection site was observed in 10 subjects.

No other complications were reported, according to sources.

In all, MMCRI had screened 53 children, of which 23 had to be rejected as they were ineligible for the trial, on account of either having antibodies or active infection.

According to Dr C P Nanjaraj, Dean at MMCRI, screening 50 children in each age group: 12 to 18 years, 6 to 12 years, and 2 to 6 years, said, "During screening, we shall draw blood samples for Covid IgG antibodies and nasopharyngeal swabs for RT-PCR tests.

"If IgG antibodies and RT-PCR are negative, they (children) will be eligible to get into the study.

"The study subjects (children) will be given two doses of vaccine 28 days apart, and will be followed up for six months for safety analysis."